"We think that it's better for public health,
we think it's better for the campaign, that all information be
learned about to the degree possible before launching into phase two
in a large-scale way."
Dr. Brian Strom
Smallpox, even deadlier than
Anthrax, was eradicated more
than two decades ago — but
experts now fear it might be
brought back and used in a
bioterrorist attack against the
United States.
• Interactive:
Smallpox:
Find out more about the dangers
of this disease.
(CBS) There is new concern about the government's already troubled
smallpox vaccination program. Few of the half-million healthcare workers
eligible for innoculation under phase one of the program chose to get
vaccinated.
And some healh experts are warning -- not so fast.
Some states, including Florida and Virginia, are already moving ahead with
phase two of the government's smallpox vaccination program, to include as
many as three million firefighters, police and paramedics.
But a new report issued by an Institute of Medicine panel says all
civilian vaccinations should temporarily stop, and that the federal
government should actively get out the word to states, CBS News
Correspondent Sharyl Attkisson reports.
The Committee on Smallpox Vaccine Implementation earlier recommended a
"pause" in civilian smallpox vaccination, in part due to unexpected
adverse events emerging in what was already known to be the most toxic
vaccine on the market.
The head of the committee, Dr. Brian Strom, says the Centers for Disease
Control, which advises states on their vaccine programs, recently accepted
the idea of a pause. Yet, Strom says, the CDC didn't explicitly notify
states of this change of heart. Tuesday's report encourages the CDC to
take more action.
"What we're asking is one step further – that they go out of their way to
make it easy for those states who want to pause to make it easy for them
to be able do that," says Strom.
"We think that it's better for public health, we think it's better for the
campaign, that all information be learned about to the degree possible
before launching into phase two in a large-scale way. We thought that it
was very important that people stop, they take stock of where they are,
look to learn from the experience gained today before proceeding onward
with the rest of the campaign."
The report says several issues should be resolved "before deciding whether
and how to proceed with vaccination."
On the issue of safety, the report says a "pause" is needed to collect and
evaluate adverse event reports. Although every civilian who receives the
smallpox vaccine is supposed to be individually tracked, only 34 percent
of vaccinees have made it into the surveillance system so far; two-thirds
have not.
"Some adverse events might not arouse concern on a state level, but
aggregated nationally, new patterns could emerge," says the report.
"Cardiac complications were unexpected adverse events, and there may be
others."
Says Strom: "At this point only about one-third of the civilian patients
who've gotten the vaccination are in the surveillance system. And one of
the things we'd like know about is the outcomes in the other two-thirds of
the patients."
The report also says the consent forms and educational materials should be
revised with updated material and information that can be understood
clearly by firefighters, police and paramedics instead of the health care
workers who were targeted in phase one.
"In many ways, the most important message we have is that maximum
preparedness doesn't require huge numbers; it requires it be done very
safely and very carefully. That's what's been done so far. The CDC has
done a terrific job. And the CDC should use (a pause in the state's
vaccination programs) as an opportunity to learn maximally from the
experience to date, in order to be sure that as we launch into phase two
it's given to the right people, it's the right size and it's done as
safely as possible," says Strom.
The panel that issued the new report was created by the Institute of
Medicine to advise the federal government on implementing the smallpox
vaccine program.
But it's unclear whether the federal government will take the committee's
advice to publicly encourage states to "pause." Doing so would highlight
touchy subjects in some political circles: unexpected adverse events, and
what some view as the lackluster response to President Bush's smallpox
vaccine program. Out of roughly 500,000 eligible health care workers, only
a small fraction, 30,000, volunteered to receive the vaccine in phase one.
Many who refused the vaccine were concerned about the vaccine's risks.
Some states have already stopped their smallpox vaccination programs on
their own, others are "skipping" phase two altogether.
The inherent conflict involved in this issue is apparent. Strom, chair of
the committee that wrote the new report, told CBS News it was
issued quickly because of its importance and urgency. Yet a spokesman for
the Institute of Medicine told reporters, in advance, there would be
nothing particularly newsworthy in the committee's report.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.